Annual Current Liabilities
$5.55 M
-$1.38 M-19.90%
31 December 2023
Summary:
Sunshine Biopharma annual total current liabilities is currently $5.55 million, with the most recent change of -$1.38 million (-19.90%) on 31 December 2023. During the last 3 years, it has risen by +$4.50 million (+428.09%). SBFMW annual current liabilities is now -19.90% below its all-time high of $6.93 million, reached on 31 December 2022.SBFMW Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Current Liabilities
$4.53 M
-$771.00 K-14.55%
30 September 2024
Summary:
Sunshine Biopharma quarterly total current liabilities is currently $4.53 million, with the most recent change of -$771.00 thousand (-14.55%) on 30 September 2024. Over the past year, it has dropped by -$559.61 thousand (-11.00%). SBFMW quarterly current liabilities is now -34.66% below its all-time high of $6.93 million, reached on 31 December 2022.SBFMW Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
SBFMW Current Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -19.9% | -11.0% |
| 3 y3 years | +428.1% | +860.2% |
| 5 y5 years | +508.4% | +409.3% |
SBFMW Current Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -19.9% | +5985.6% | -34.7% | +4863.9% |
| 5 y | 5 years | -19.9% | +5985.6% | -34.7% | +4863.9% |
| alltime | all time | -19.9% | >+9999.0% | -34.7% |
Sunshine Biopharma Current Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $4.53 M(-14.5%) |
| June 2024 | - | $5.30 M(-18.9%) |
| Mar 2024 | - | $6.53 M(+17.7%) |
| Dec 2023 | $5.55 M(-19.9%) | $5.55 M(+9.1%) |
| Sept 2023 | - | $5.09 M(+9.2%) |
| June 2023 | - | $4.66 M(-32.5%) |
| Mar 2023 | - | $6.91 M(-0.4%) |
| Dec 2022 | $6.93 M(+7497.4%) | $6.93 M(+1343.3%) |
| Sept 2022 | - | $480.21 K(+358.7%) |
| June 2022 | - | $104.68 K(+9.9%) |
| Mar 2022 | - | $95.23 K(+4.4%) |
| Dec 2021 | $91.23 K(-91.3%) | $91.23 K(-80.7%) |
| Sept 2021 | - | $471.63 K(-25.8%) |
| June 2021 | - | $635.56 K(-26.5%) |
| Mar 2021 | - | $864.79 K(-17.7%) |
| Dec 2020 | $1.05 M(+26.1%) | $1.05 M(+40.6%) |
| Sept 2020 | - | $747.85 K(+9.0%) |
| June 2020 | - | $686.20 K(-11.1%) |
| Mar 2020 | - | $772.29 K(-7.3%) |
| Dec 2019 | $833.53 K(-8.7%) | $833.53 K(-6.3%) |
| Sept 2019 | - | $889.19 K(-3.9%) |
| June 2019 | - | $925.69 K(-17.3%) |
| Mar 2019 | - | $1.12 M(+22.7%) |
| Dec 2018 | $912.48 K(+21.5%) | $912.48 K(+22.1%) |
| Sept 2018 | - | $747.13 K(-34.3%) |
| June 2018 | - | $1.14 M(-3.7%) |
| Mar 2018 | - | $1.18 M(+57.2%) |
| Dec 2017 | $751.14 K(+174.0%) | $751.14 K(+23.2%) |
| Sept 2017 | - | $609.87 K(-21.9%) |
| June 2017 | - | $780.62 K(+174.4%) |
| Mar 2017 | - | $284.45 K(+3.8%) |
| Dec 2016 | $274.10 K(-78.4%) | $274.10 K(-0.9%) |
| Sept 2016 | - | $276.68 K(-77.2%) |
| June 2016 | - | $1.21 M(+2.3%) |
| Mar 2016 | - | $1.19 M(-6.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2015 | $1.27 M(+139.2%) | $1.27 M(+170.5%) |
| Sept 2015 | - | $469.57 K(+7.7%) |
| June 2015 | - | $436.07 K(+15.0%) |
| Mar 2015 | - | $379.23 K(-28.6%) |
| Dec 2014 | $531.00 K(+1263.3%) | $531.00 K(+16.3%) |
| Sept 2014 | - | $456.64 K(+19.5%) |
| June 2014 | - | $382.27 K(+106.6%) |
| Mar 2014 | - | $185.04 K(+375.1%) |
| Dec 2013 | $38.95 K(-39.5%) | $38.95 K(+65.5%) |
| Sept 2013 | - | $23.53 K(+60.2%) |
| June 2013 | - | $14.68 K(-34.3%) |
| Mar 2013 | - | $22.35 K(-65.3%) |
| Dec 2012 | $64.37 K(+1774.4%) | $64.37 K(+333.3%) |
| Sept 2012 | - | $14.86 K(-49.5%) |
| June 2012 | - | $29.39 K(+43.3%) |
| Mar 2012 | - | $20.52 K(+497.5%) |
| Dec 2011 | $3434.00(-69.9%) | $3434.00(-24.4%) |
| Sept 2011 | - | $4545.00(>+9900.0%) |
| June 2011 | - | $0.00(-100.0%) |
| Mar 2011 | - | $330.00(-97.1%) |
| Dec 2010 | $11.40 K(-20.3%) | $11.40 K(-52.0%) |
| Sept 2010 | - | $23.78 K(+42.4%) |
| June 2010 | - | $16.70 K(+4.4%) |
| Mar 2010 | - | $15.99 K(>+9900.0%) |
| Dec 2009 | $14.31 K(-37.1%) | - |
| Oct 2009 | - | $0.00(-100.0%) |
| July 2009 | - | $43.36 K(+25.3%) |
| Apr 2009 | - | $34.59 K(+18.0%) |
| Jan 2009 | - | $29.31 K(+9.9%) |
| Oct 2008 | - | $26.68 K(+17.3%) |
| July 2008 | $22.74 K(+1415.9%) | $22.74 K(+30.9%) |
| Apr 2008 | - | $17.37 K(+584.4%) |
| Jan 2008 | - | $2538.00(-22.8%) |
| Oct 2007 | - | $3288.00 |
| July 2007 | $1500.00 | - |
FAQ
- What is Sunshine Biopharma annual total current liabilities?
- What is the all time high annual current liabilities for Sunshine Biopharma?
- What is Sunshine Biopharma annual current liabilities year-on-year change?
- What is Sunshine Biopharma quarterly total current liabilities?
- What is the all time high quarterly current liabilities for Sunshine Biopharma?
- What is Sunshine Biopharma quarterly current liabilities year-on-year change?
What is Sunshine Biopharma annual total current liabilities?
The current annual current liabilities of SBFMW is $5.55 M
What is the all time high annual current liabilities for Sunshine Biopharma?
Sunshine Biopharma all-time high annual total current liabilities is $6.93 M
What is Sunshine Biopharma annual current liabilities year-on-year change?
Over the past year, SBFMW annual total current liabilities has changed by -$1.38 M (-19.90%)
What is Sunshine Biopharma quarterly total current liabilities?
The current quarterly current liabilities of SBFMW is $4.53 M
What is the all time high quarterly current liabilities for Sunshine Biopharma?
Sunshine Biopharma all-time high quarterly total current liabilities is $6.93 M
What is Sunshine Biopharma quarterly current liabilities year-on-year change?
Over the past year, SBFMW quarterly total current liabilities has changed by -$559.61 K (-11.00%)